Resultados de la búsqueda 181-190 of 8993 for ibd

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

2. Prophylactic Table ID File.indd

   Page 1.

3. Descripción general - Mayo Clinic

   Most people with this type of cancer have an ongoing liver condition, such as cirrhosis caused by hepatitis B or hepatitis C infection. Hepatocellular carcinoma ...

4. Untitled

   Page 1. Page 2. Page 3. Page 4.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review clinical records of ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

8. Estar en forma - Mayo Clinic

   News. 2025. Your abdominal core: Expert shares tips for protecting a part of the body you may not think about April 03, 2025, 04:02 p.m. CDT.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...